lamivudine has been researched along with Bilateral Headache in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garner, O; Iardino, A; Lorusso, G; Lotta, F | 1 |
| Domingo, P; Rivero, A | 1 |
| Ali, HY | 1 |
| Duncan, B; Laurent, AL; Lloyd, P; Moore, KH; Morris, DM; O'Mara, MJ; Pakes, GE; Shaw, S | 1 |
| Danner, SA; Donn, KH; Hall, ST; Harker, AJ; Hussey, EK; Jonker, P; Lange, JM; van Leeuwen, R | 1 |
1 review(s) available for lamivudine and Bilateral Headache
| Article | Year |
|---|---|
[Safety profile of dolutegravir].
Topics: Bone Remodeling; Clinical Trials as Topic; Creatinine; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Gastrointestinal Diseases; Headache; Hepatitis, Viral, Human; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Immune Reconstitution Inflammatory Syndrome; Kidney Tubules; Lamivudine; Lipid Metabolism; Mood Disorders; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxazines; Piperazines; Pyridones; Respiration Disorders; Sleep Initiation and Maintenance Disorders | 2015 |
3 trial(s) available for lamivudine and Bilateral Headache
| Article | Year |
|---|---|
Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody.
Topics: Adult; Carrier State; Enzyme-Linked Immunosorbent Assay; Female; Headache; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin M; Iraq; Lamivudine; Male; Middle Aged; Nausea; Reverse Transcriptase Inhibitors; Treatment Outcome | 2003 |
Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption.
Topics: Absorption; Adolescent; Adult; Anti-HIV Agents; Area Under Curve; Cross-Over Studies; Eating; Fasting; Female; Food-Drug Interactions; Headache; Humans; Lamivudine; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Tablets; Therapeutic Equivalency; Zidovudine | 1999 |
The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I study.
Topics: Administration, Oral; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Headache; HIV Infections; Humans; Infusions, Intravenous; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine | 1992 |
1 other study(ies) available for lamivudine and Bilateral Headache
| Article | Year |
|---|---|
Headache in an HIV-Positive Patient: Dangerous Interaction.
Topics: Adult; Anti-HIV Agents; Anticoagulants; Cilostazol; Cytochrome P-450 CYP3A Inhibitors; Dideoxynucleosides; Drug Combinations; Drug Interactions; Enoxaparin; Ergotamine; Ergotism; Headache; HIV Infections; Humans; Ischemia; Lamivudine; Lower Extremity; Male; Nitroglycerin; Ritonavir; Saquinavir; Tetrazoles; Tibial Arteries; Ultrasonography, Doppler, Color; Vasoconstrictor Agents; Vasodilator Agents | 2018 |